Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
8/2018 not set
TALENT Biotechs
TALENT Biotechs Overview
TALENT Biotechs develops cannabidiol-based therapies.TALENT screens and locates pharmaceutical and medical technologies patented in the global market and leverages the development process of research and clinical trials throughPhase II into a Phase IIIstarting point. TALENThas suggestedthe use of cannabidiol for the prevention and treatment of graft-versus-host disease, which is a major cause of morbidity and mortality withallogeneic hematopoietic stem cell transplantation. TALENT Biotechs has been acquired by Kalytera Therapeutics, Beverly, Massachusetts, United States.